Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06080399

Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease

Sponsor: University Hospital, Toulouse

View on ClinicalTrials.gov

Summary

Since our previous study has shown that some personality dimensions were associated with Quality of Life (QoL) amelioration after Deep Brain Stimulation (DBS) in Parkinson's disease (PD), the investigators aim to evaluate the impact of personality dimensions on therapeutic response after another second-line treatment: the continuous subcutaneous apomorphine infusion (CSAI). Moreover, the investigators would like to evaluate the potential evolution of personality dimensions through CSAI. The investigators also aim to evaluate other bio-psycho-social factors (representations of the disease, ways of copying and social support) influence on QoL amelioration after DBS.

Official title: Could Psycho-bio-social Context and Personality be a Predictive Factor of Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease Patients? - PERSO-PERF Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

70

Start Date

2024-02-15

Completion Date

2026-04-01

Last Updated

2024-08-29

Healthy Volunteers

No

Interventions

OTHER

Continuous subcutaneous apomorphine infusion (CSAI)

the CSAI proposed in the usual healthcare pathway of each PD patients included

Locations (10)

Chu de Lyon

Bron, France

Hopital Gabriel Montpied

Clermont-Ferrand, France

Chu de Grenoble

Grenoble, France

Chu Limoges

Limoges, France

Chu de Nancy

Nancy, France

Chu de Nice

Nice, France

Chu de Poitiers

Poitiers, France

Chu de Rennes

Rennes, France

Chu de Rouen

Rouen, France

Chu de Toulouse

Toulouse, France